Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent miscarriage

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 112, Issue 8, 2005, Pages 1096-1101

  Raghupathy, Raj ^a   Al Mutawa, Esraa ^a   Makhseed, Ma'asoumah ^a   Azizieh, Fawaz ^a   Szekeres Bartho, Julia ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b UNIVERSITY OF PÉCS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGESTAGEN; DYDROGESTERONE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; MIFEPRISTONE; PHYTOHEMAGGLUTININ; PROGESTERONE; PROGESTERONE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; HORMONE ANTAGONIST; PIBF1 PROTEIN, HUMAN; PLACENTA PROTEIN; TUMOR NECROSIS FACTOR;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENSITY GRADIENT; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LYMPHOCYTE; MATERNITY WARD; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEPTOR UPREGULATION; RECURRENT DISEASE; SEDIMENTATION; SPONTANEOUS ABORTION; SUPERNATANT; VENOUS BLOOD; BIOSYNTHESIS; CELL CULTURE; DRUG ANTAGONISM; IMMUNOLOGY; METABOLISM; MULTICENTER STUDY; PREGNANCY; RECURRENT ABORTION; TH1 CELL; TH2 CELL; UPREGULATION;

ABORTION, HABITUAL; CELLS, CULTURED; CYTOKINES; DYDROGESTERONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONE ANTAGONISTS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; INTERLEUKIN-6; MIFEPRISTONE; PREGNANCY; PREGNANCY PROTEINS; PROSPECTIVE STUDIES; TH1 CELLS; TH2 CELLS; TUMOR NECROSIS FACTORS; UP-REGULATION;

EID: 15844395561     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2005.00633.x     Document Type: Article

References (39)

1. Hill JA, Anderson DJ, Polgar K. T helper 1-type cellular immunity to trophoblast in women with recurrent spontaneous abortions. JAMA 1995;273:1933-1958.
2. Raghupathy R. Pregnancy: success and failure within the Th1/Th2/Th3 paradigm. Semin Immunol 2001;13:219-227.
3. Stray-Pederson B, Stray-Pederson S. Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol 1984;148:140-151.
4. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today 1993;14:353-356.
5. Guilbert LJ. There is a bias against type 1 (inflammatory) cytokine expression and function in pregnancy. J Reprod Immunol 1996;32:105-110.
6. Chaouat G, Cayol V, Mairovitz V, Dubanchet S. Localization of the Th2 cytokines IL-3, IL-4, IL-10 at the murine fetomaternal interface during pregnancy. In: Gupta SK, editor. Reproductive Immunology. New Delhi: Narosa Publishing House, 1999:61-70.
7. Mosmann TR, Sad S. The expanding universe of T-cell subsets. Immunol Today 1996;17:138-146.
8. Marzi M, Vigano A, Trabattoni D, et al. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 1996;106:127-133.
9. Raghupathy R, Makhseed M, Azizieh F, Omu A, Gupta M, Farhat R. Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Hum Reprod 2000;15:713-718.
10. Raghupathy R, Makhseed M, Azizieh F, Hassan N, Al-Azemi M, Al-Shamali E. Maternal Th1- and Th2-type reactivity to placental antigens in normal human pregnancy and unexplained recurrent spontaneous abortions. Cell Immunol 1999;196:122-130.
11. Piccinni M-P, Beloni L, Livi C, Maggi E, Scarselli G, Romagnani S. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nature (Med) 1998;4:1020-1024.
12. Bates MD, Quenby S, Takakuwa K, Johnson PM, Vince GS. Aberrant cytokine production by peripheral blood mononuclear cells in recurrent pregnancy loss? Human Reprod 2002;17:2439-2444.
13. Shimada S, Iwabuchi K, Kato EH, et al. No difference in natural-killer-T cell population but Th2/Tc2 predominance in peripheral blood of recurrent aborters. Am J Reprod Immunol 2003;50:334-339.
14. Yamada H, Morikawa M, Furuta I, et al. Intravenous immunoglobulin treatment in women with recurrent abortions: increased cytokine levels and reduced Th1/Th2 lymphocyte ratio in peripheral blood. Am J Reprod Immunol 2003;49:84-89.
15. Zourbas S, Dubanchet S, Martal J, Chaouat G. Localization of proinflammatory (IL-12, IL-15) and anti-inflammatory (IL-11, IL-13) cytokines at the feto-maternal interface during murine pregnancy. Clin Exp Immunol 2001;126:519-528.
16. Jenkins C, Roberts J, Wilson R, MacLean MA, Shilito J, Walker JJ. Evidence of a Th1 type response associated with recurrent miscarriage. Fertil Steril 2000;73:1206-1208.
17. Piccinni MP, Scaletti C, Vultaggio A, Maggi E, Romagnani S. Defective production of LIF, M-CSF and Th2-type cytokines by T cells at fetomaternal interface is associated with pregnancy loss. J Reprod Immunol 2001;52:35-43.
18. Makhseed M, Raghupathy R, Azizieh F, Al-Shamali E, Ashkanani L. Th1 and Th2 cytokine profiles in recurrent aborters with successful pregnancy and with subsequent abortions. Hum Reprod 2001;16:2219-2226.
19. Laird SM, Tuckerman EM, Cork BA, Linjawi S, Blakemore AI, Li TC. A review of immune cells and molecules in women with recurrent miscarriage. Hum Reprod Update 2003;9:163-174.
20. Lim KJ, Odukoya OA, Ajjan RA, Li TC, Weetman AP, Cooke ID. The role of T-helper cytokines in human reproduction. Fertil Steril 2000;73:136-142.
21. Stites DP, Bugbee S, Siiteri PK. Differential actions of progesterone and cortisol on lymphocyte and monocyte interaction during lymphocyte activation-relevance to immunosuppression in pregnancy. J Reprod Immunol 1983;5:215-228.
22. Piccinni MP, Giudizi MG, Biagiotti R, et al. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established T cell clones. J Immunol 1995;155:128-133.
23. Choi BC, Polgar K, Xiao L, Hill JA. Progesterone inhibits in vitro embryotoxic Th1 cytokine production to trophoblast in women with recurrent pregnancy loss. Hum Reprod 2000;15(Suppl 1):46-59.
24. Szekeres-Bartho J. Immunosuppression by Progesterone in Pregnancy. Boca Raton: CRC Press, 1992.
25. Szekeres-Bartho J, Par G, Dombay G, Smart CY, Volgyi Z. The anti-abortive effect of progesterone-induced blocking factor in mice is manifested by modulating NK activity. Cell Immunol 1997;177:194-199.
26. Haimovici F, Hill JA, Anderson DJ. The effects of soluble products of activated lymphocytes and macrophages on blastocyst implantation events in vitro. Biol Reprod 1991;44:69-76.
27. Yui J, Garcia-Lloret M, Wegmann TG, Guilbert L. Cytotoxicity of tumor necrosis factor-α (TNF-α) and gamma-interferon (IFN-γ) against primary human placental trophoblasts. Placenta 1994;15:819-828.
28. Chaouat G, Menu E, Clark DA, Dy M, Minkowski M, Wegmann TG. Control of fetal survival in CBAxDBA/2 mice by lymphokine therapy. J Reprod Fertil 1990;89:447-457.
29. Knackstedt M, Ding JW, Arck PC, et al. Activation of the novel prothrombinase, fg12, as a basis for the pregnancy complications spontaneous abortion and pre-eclampsia. Am J Reprod Immunol 2001;46:196-210.
30. Szekeres-Bartho J, Wegmann TG. A progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance. J Reprod Immunol 1996;31:81-95.
31. Szekeres-Bartho J, Faust Z, Varga P. The expression of a progesterone-induced immunomodulatory protein in pregnancy lymphocytes. Am J Reprod Immunol 1995;34:342-348.
32. Szekeres-Bartho J, Chaouat G. Lymphocyte-derived, progesterone-induced blocking factor corrects resorption in a murine abortion system. Am J Reprod Immunol 1990;23:26-28.
33. Szekeres-Bartho J, Philibert D, Chaouat G. Progesterone suppression of pregnancy lymphocytes is not mediated by glucocorticoid effect. Am J Reprod Immunol 1990;23:42-43.
34. Chaouat G, Ledee-Bataille N, Dubanchet S, Zourbas S, Sandra O, Martal J. Th1/Th2 paradigm in pregnancy: paradigm lost? Int Arch Allergy Immunol 2004;134:93-119.
35. Stanczyk FZ. Pharmacokinetics of progesterone administered by the oral and parenteral routes. J Reprod Med 1999;44:141-147.
36. Simon JA, Robinson DE, Andrews MC, et al. The absorption of oral micronised progesterone: the effect of food, dose proportionality and comparison with intramuscular progesterone. Fertil Steril 1993;60:26-33.
37. Maxson WS, Hargrove JT. Bioavailability of oral micronized progesterone. Fertil Steril 1985;44:622-626.
38. Tavaniotou A, Smitz J, Bourgain C, Devroey P. Comparison between different routes of progesterone administration as luteal phase support in infertility treatments. Hum Reprod Update 2000;6:139-148.
39. McAuley JW, Kroboth FJ, Kroboth PD. Oral administration of micronized progesterone-a review and more experience. Pharmacotherapy 1996;16:453-457.